Research Developments in Atopic Dermatitis

Safety, Efficacy and Pharmacokinetics of Crisaborole Ointment 2% in Infants Age Three to Less Than 24 Months with Mild-to-Moderate Atopic Dermatitis


Listen Later

This poster was presented by Dr. Schlessinger and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.

This overview is provided by Dr. Steve Feldman.

...more
View all episodesView all episodes
Download on the App Store

Research Developments in Atopic DermatitisBy Annenberg Center for Health Sciences at Eisenhower


More shows like Research Developments in Atopic Dermatitis

View all
Derms and Conditions by Dermsquared

Derms and Conditions

52 Listeners